Groowe / Newsroom / XNCR

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

XNCR News

Xencor, Inc.

Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

businesswire.com Oct 14, 2025 6:51 PM